Hoot Professionals
Yuki Yoshizawa
MSc | Senior Investment Advisor – M&A & Medical Technology
About Yuki
Based in Dubai, Yuki Yoshizawa serves as a crucial bridge connecting Japanese medical technology innovation with capital markets in the Gulf region. He specializes in advising on acquisitions, growth equity investments, and joint-venture structures specifically tailored for cutting-edge therapeutic devices.
At MCO I, a Dubai platform dedicated to importing Japanese technology into the GCC, Yuki leads deal sourcing and financing efforts. He plays a key role in headline projects like mediVR KAGURA®, an Osaka University spin-out utilizing immersive VR for neuro-rehabilitation, which is now being deployed in over 120 healthcare facilities worldwide thanks to Yuki's efforts in securing funding and partnerships.
Yuki is a regular speaker at prominent industry events such as MEDTEC Japan and Arab Health. There, he decodes complex topics like reimbursement pathways, Good Manufacturing Practice (GMP) compliance, and ESG-linked valuation models, providing valuable insights for both investors and med-tech founders.
Areas of Expertise
Med-Tech Investment (Japan-GCC)
Structuring acquisitions, growth equity, and joint ventures connecting Japanese innovators with Gulf investors.
Deal Sourcing & Financing
Leading deal identification and securing financing for high-profile medical technology projects entering the GCC.
Cross-Border M&A (Med-Tech)
Advising on the complexities of cross-border mergers and acquisitions within the medical technology sector.
Regulatory & Valuation Advisory
Expertise in reimbursement pathways, GMP compliance, and ESG-linked valuation models for med-tech.
Career & Education
Senior Investment Advisor
Hoot Innovation Law Hub (Current Role Implied)
Focusing on M&A and Medical Technology, bridging Japanese innovation with GCC capital.
Deal Sourcing & Financing Lead
MCO I (Dubai)
Leads efforts to import Japanese technology to the GCC, managing projects like mediVR KAGURA®.
Industry Speaker
MEDTEC Japan & Arab Health
Regularly presents on reimbursement, GMP compliance, and ESG valuation in med-tech.
MSc [Specify Field]
University/Institution [Specify if known]
EducationNotable Projects & Contributions
- Led deal sourcing and financing for mediVR KAGURA® (Osaka University spin-out), facilitating rollout to 120+ healthcare facilities.
- Advises on acquisitions, growth equity, and joint ventures for cutting-edge therapeutic device companies entering the GCC.
- Regular speaker decoding reimbursement, GMP compliance, and ESG valuation at MEDTEC Japan and Arab Health.
- Connects Japanese med-tech innovators with GCC investors, facilitating cross-border M&A and growth funding.